The development comes after private-equity firm ChrysCapital’s ac
quisition of the entire 70.68 per cent stake in Novartis India Ltd

The development comes after private-equity firm ChrysCapital’s acquisition of the entire 70.68 per cent stake in Novartis India Ltd

The development comes after private-equity firm ChrysCapital’s ac
quisition of the entire 70.68 per cent stake in Novartis India Ltd